{"id":61638,"date":"2022-01-28T09:49:00","date_gmt":"2022-01-28T02:49:00","guid":{"rendered":"https:\/\/www.xinwengao.com\/cn\/pr\/2022012809490061638"},"modified":"2022-01-28T17:59:01","modified_gmt":"2022-01-28T09:59:01","slug":"haemalogix%e4%b8%8e%e9%be%99%e6%b2%99%e5%90%88%e4%bd%9c%e7%94%9f%e4%ba%a7%e5%a4%9a%e5%8f%91%e6%80%a7%e9%aa%a8%e9%ab%93%e7%98%a4%e5%80%99%e9%80%89%e8%8d%af%e7%89%a9kappamab","status":"publish","type":"post","link":"https:\/\/www.xinwengao.com\/cn\/pr\/2022012809490061638","title":{"rendered":"HaemalogiX\u4e0e\u9f99\u6c99\u5408\u4f5c\u751f\u4ea7\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u5019\u9009\u836f\u7269KappaMab"},"content":{"rendered":"<ul type=\"disc\">\n<li>\u9f99\u6c99\u5c06\u5728\u5e7f\u5dde\u65b0\u751f\u4ea7\u57fa\u5730\u4e3aHaemaLogiX\u7684\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u5019\u9009\u836f\u7269KappaMab\u63d0\u4f9b\u4e34\u5e8a\u8bd5\u9a8c\u6240\u9700\u8981\u7684\u539f\u6db2\u751f\u4ea7\u3002 <\/li>\n<li>HaemalogiX\u5c06\u5145\u5206\u501f\u529b\u9f99\u6c99\u7684\u6cd5\u89c4\u4e13\u4e1a\u77e5\u8bc6\u3001\u5168\u7403\u751f\u4ea7\u7f51\u7edc\u4ee5\u53ca\u5728\u751f\u4ea7\u5355\u514b\u9686\u6297\u4f53\u65b9\u9762\u7684\u4e30\u5bcc\u7ecf\u9a8c\u3002<\/li>\n<\/ul>\n<p><p>\u745e\u58eb\u5df4\u585e\u5c14\u548c\u6fb3\u5927\u5229\u4e9a\u6089\u5c3c2022\u5e741\u670828\u65e5 \/\u7f8e\u901a\u793e\/ &#8212; HaemaLogiX\u5df2\u4e0e\u5168\u7403\u5236\u836f\u3001\u751f\u7269\u6280\u672f\u4e0e\u8425\u517b\u5e02\u573a\u7684\u4f18\u79c0\u5408\u4f5c\u4f19\u4f34\u9f99\u6c99\u7b7e\u7f72\u534f\u8bae\uff0c\u4e3aHaemaLogiX\u751f\u4ea7\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u5019\u9009\u836f\u7269KappaMab\u7684\u4e0b\u4e00\u4e2a\u4e34\u5e8a\u6279\u6b21\uff08cGMP\uff09\u3002HaemaLogiX\u662f\u4e00\u5bb6\u751f\u7269\u6280\u672f\u516c\u53f8\uff0c\u4e3b\u8981\u4ece\u4e8b\u9488\u5bf9\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u7684\u65b0\u578b\u5355\u514b\u9686\u6297\u4f53\u7597\u6cd5\u65b9\u9762\u7684\u4e34\u5e8a\u9636\u6bb5\u5f00\u53d1\u5de5\u4f5c\u3002<\/p>\n<p>KappaMab\u662f\u4e00\u79cd\u5d4c\u5408\u578bIgG1\u5355\u514b\u9686\u6297\u4f53\uff0c\u53ef\u4e0e\u4ec5\u5728\u9aa8\u9ad3\u7624\u764c\u7ec6\u80de\u8868\u9762\u53d1\u73b0\uff08\u6b63\u5e38\u7ec6\u80de\u8868\u9762\u4e0d\u8868\u8fbe\uff09\u7684\u9776\u70b9\uff0c\u5373kappa\u9aa8\u9ad3\u7624\u6297\u539f\uff08KMA\uff09\u7ed3\u5408\u3002KappaMab\u53ef\u4e0e\u9aa8\u9ad3\u7624\u7ec6\u80de\u7279\u5f02\u6027\u7ed3\u5408\uff0c\u4f7f\u60a3\u8005\u514d\u75ab\u7cfb\u7edf\u8bc6\u522b\u51fa\u5f02\u5e38\u7ec6\u80de\uff0c\u89e6\u53d1\u5929\u7136\u514d\u75ab\u5e94\u7b54\uff0c\u5bf9\u9aa8\u9ad3\u7624\u7ec6\u80de\u8fdb\u884c\u653b\u51fb\u5e76\u6740\u706d\u3002\u6700\u7ec8\uff0c\u60a3\u8005\u4f53\u5185\u4ec5\u764c\u7ec6\u80de\u51cf\u5c11\uff0c\u800c\u6b63\u5e38\u7684\u5065\u5eb7\u7ec6\u80de\u53ef\u514d\u53d7\u514d\u75ab\u7cfb\u7edf\u7684\u653b\u51fb\u3002<\/p>\n<p>\u8fc4\u4eca\u4e3a\u6b62\uff0c\u5df2\u6709\u4e09\u9879\u4e34\u5e8a\u8bd5\u9a8c\u5bf9KappaMab\u8fdb\u884c\u4e86\u7814\u7a76\uff0c\u8fd9\u4e9b\u7814\u7a76\u7ed3\u679c\u5747\u8868\u660eKappaMab\u5177\u6709\u826f\u597d\u7684\u5b89\u5168\u6027\u7279\u5f81\uff0c\u4e14\u4e0d\u5177\u6709\u5355\u6b21\u3001\u591a\u6b21\u7ed9\u836f<sup>[1],[2],[3]<\/sup>\u540e\u5242\u91cf\u9650\u5236\u6027\u6bd2\u6027\u3002\u5728\u8fd1\u671f\u5f00\u5c55\u7684\u4e00\u9879IIb\u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\uff0c\u4e0e\u6765\u90a3\u5ea6\u80fa\u8054\u5408\u5730\u585e\u7c73\u677e\u6cbb\u7597\u76f8\u6bd4\uff08\u5bf9\u7167\u7ec4\uff09\uff0cKappaMab\u534f\u540c\u6765\u90a3\u5ea6\u80fa\uff08\u514d\u75ab\u8c03\u8282\u6027\u9170\u4e9a\u80fa\u7c7b\u836f\u7269\uff08IMiD\uff09\uff09\u8054\u5408\u5730\u585e\u7c73\u677e\u6cbb\u7597\uff0c\u53ef\u63d0\u9ad8\u590d\u53d1\u6027\u3001\u96be\u6cbb\u6027\u591a\u53d1\u6027\u9aa8\u9ad3\u7624<sup>2<\/sup>\u60a3\u8005\u7684\u75be\u75c5\u7f13\u89e3\u7387\uff0c\u540c\u65f6\u6539\u5584\u7f13\u89e3\u8d28\u91cf\u3002<\/p>\n<p><b>HaemaLogiX<\/b><b>\u8463\u4e8b\u957f\u517c\u9996\u5e2d\u6267\u884c\u5b98<\/b><b><span class=\"xn-person\">Bryce Carmine<\/span><\/b><b>\u8868\u793a\uff1a<\/b>\u201c\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u662f\u5168\u7403\u7b2c\u4e8c\u5927\u5e38\u89c1\u7684\u6076\u6027\u8840\u6db2\u80bf\u7624\u3002\u6839\u636e2019\u5e74\u6570\u636e\uff0c\u4ec5\u5728\u7f8e\u56fd\u9884\u8ba1\u6bcf\u5e74\u5c31\u6709\u65b0\u53d1\u75c5\u4f8b3.2\u4e07\u4f8b\uff0c\u6b7b\u4ea1\u4eba\u6570\u8d851.25\u4e07\u4eba\uff0c\u6b27\u6d32\u7684\u53d1\u75c5\u7387\u5927\u81f4\u76f8\u5f53\u3002\u7531\u4e8e\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u65e0\u6cd5\u6839\u6cbb\uff0c\u6211\u4eec\u5e94\u63d0\u4f9b\u66f4\u591a\u6cbb\u7597\u65b9\u6848\u8ba9\u60a3\u8005\u9009\u62e9\u3002\u6211\u4eec\u671f\u5f85\u5c06KappaMab\u8054\u5408\u6807\u51c6\u6cbb\u7597\u91cd\u65b0\u6295\u5165\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4e0e\u9f99\u6c99\u7b7e\u8ba2\u7684\u8fd9\u9879\u534f\u8bae\u662f\u91cd\u8981\u4e00\u6b65\uff0c\u65e8\u5728\u4e3a\u6211\u4eec\u5373\u5c06\u8fdb\u884c\u7684\u8bd5\u9a8c\u63d0\u4f9b\u836f\u54c1\u3002\u201d<\/p>\n<p>\u6839\u636e\u534f\u8bae\u6761\u6b3e\uff0c\u9f99\u6c99\u5c06\u5728\u5176\u914d\u5907\u5148\u8fdb\u7684\u4e2d\u56fd\u5e7f\u5ddecGMP\u54fa\u4e73\u52a8\u7269\u7ec6\u80de\u65b0\u751f\u4ea7\u57fa\u5730\u4e3aKappaMab\u4e34\u5e8a\u8bd5\u9a8c\u63d0\u4f9b\u539f\u6db2\u751f\u4ea7\uff0c\u8be5\u57fa\u5730\u88c5\u8f7d\u67092\u4e2a1000L\u548c2\u4e2a2000L\u7684\u4e00\u6b21\u6027\u751f\u7269\u53cd\u5e94\u5668\u3002HaemalogiX\u5c06\u5145\u5206\u5229\u7528\u9f99\u6c99\u7684\u6cd5\u89c4\u4e13\u4e1a\u77e5\u8bc6\u3001\u5168\u7403\u751f\u4ea7\u7f51\u7edc\u4ee5\u53ca\u5728\u751f\u4ea7\u5355\u514b\u9686\u6297\u4f53\u65b9\u9762\u7684\u4e30\u5bcc\u7ecf\u9a8c\u3002<\/p>\n<p><b>\u9f99\u6c99\u4e34\u5e8a\u5f00\u53d1\u548c\u6218\u7565\u8425\u9500\u6267\u884c\u603b\u76d1<\/b><b>Jeetendra Vaghjiani<\/b><b>\u8868\u793a\uff1a<\/b>\u201c\u6211\u4eec\u671f\u5f85\u4e0eHaemalogiX\u5efa\u7acb\u5408\u4f5c\u5173\u7cfb\uff0c\u52a0\u901f\u63a8\u52a8\u5176\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u5019\u9009\u836f\u7269\u7684\u5546\u4e1a\u5316\u8fdb\u7a0b\uff0c\u5145\u5206\u5229\u7528\u6211\u4eec\u5728\u4e2d\u56fd\u5e7f\u5dde\u5de5\u5382\u62e5\u6709\u7684\u72ec\u7279\u3001\u7075\u6d3b\u7684\u5355\u514b\u9686\u6297\u4f53\u751f\u4ea7\u80fd\u529b\u548c\u5148\u8fdb\u7684\u4e13\u4e1a\u6280\u672f\u3002\u201d<\/p>\n<p>\u8be5\u836f\u54c1\u7684\u76ee\u6807\u5b8c\u6210\u65e5\u671f\u4e3a2022\u5e74\u7b2c4\u5b63\u5ea6\u3002\u76ee\u524d\u8ba1\u5212\u4e8e2022\u5e74\u5e95\u5728\u6fb3\u5927\u5229\u4e9a\u542f\u52a8\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u5c4a\u65f6\u8be5\u836f\u54c1\u5c06\u6295\u5165\u4e34\u5e8a\u4f7f\u7528\u3002<\/p>\n<p>&nbsp;<\/p>\n<div>\n<table cellspacing=\"0\" cellpadding=\"0\" border=\"0\" class=\"prntblns\">\n<tbody>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">[1] Spencer A, Walker P, Asvadi P, et al. A preliminary study of the anti-\u03ba myeloma antigen monoclonal antibody KappaMab (MDX-1097) in pretreated patients with \u03ba-restricted multiple myeloma. <i>Blood Cancer J<\/i>. 2019; 9(8):58.<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">[2] Kalff A, Shortt J, Yuen F, et al. A Sequential Cohort Study Comparing Kappamab Alone to Kappamab, Lenalidomide and Low Dose Dexamethasone in Kappa-Restricted Relapsed Refractory Multiple Myeloma (AMaRC 01-16). <i>Blood<\/i>. 2019; 134(Supplement_1): 3144-3144.<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">[3] Spencer A, Augustson B, Mollee P, Copeman M, Asvadi P, Dunn R. Phase 2a, open-label, multi-dose study of the anti-kappa monoclonal antibody, MDX-1097, in relapsed kappa-chain restricted multiple myeloma with stable measurable disease. The European Hematology Association (EHA). Stockholm, Sweden; 2013.<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u9f99\u6c99\u5c06\u5728\u5e7f\u5dde\u65b0\u751f\u4ea7\u57fa\u5730\u4e3aHaemaLogiX\u7684\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u5019\u9009\u836f\u7269KappaMab\u63d0\u4f9b\u4e34\u5e8a\u8bd5\u9a8c\u6240\u9700\u8981\u7684\u539f\u6db2\u751f\u4ea7\u3002 HaemalogiX\u5c06\u5145\u5206\u501f\u529b\u9f99\u6c99\u7684\u6cd5\u89c4\u4e13\u4e1a\u77e5\u8bc6\u3001\u5168\u7403\u751f\u4ea7\u7f51\u7edc\u4ee5\u53ca\u5728\u751f\u4ea7\u5355\u514b\u9686\u6297\u4f53\u65b9\u9762\u7684\u4e30\u5bcc\u7ecf\u9a8c\u3002 \u745e\u58eb\u5df4\u585e\u5c14\u548c\u6fb3\u5927\u5229\u4e9a\u6089\u5c3c2022\u5e741\u670828\u65e5 \/\u7f8e\u901a\u793e\/ &#8212; HaemaLogiX\u5df2\u4e0e\u5168\u7403\u5236\u836f\u3001\u751f\u7269\u6280\u672f\u4e0e\u8425\u517b\u5e02\u573a\u7684\u4f18\u79c0\u5408\u4f5c\u4f19\u4f34\u9f99\u6c99\u7b7e\u7f72\u534f\u8bae\uff0c\u4e3aHaemaLogiX\u751f\u4ea7\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u5019\u9009\u836f\u7269KappaMab\u7684\u4e0b\u4e00\u4e2a\u4e34\u5e8a\u6279\u6b21\uff08cGMP\uff09\u3002HaemaLogiX\u662f\u4e00\u5bb6\u751f\u7269\u6280\u672f\u516c\u53f8\uff0c\u4e3b\u8981\u4ece\u4e8b\u9488\u5bf9\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u7684\u65b0\u578b\u5355\u514b\u9686\u6297\u4f53\u7597\u6cd5\u65b9\u9762\u7684\u4e34\u5e8a\u9636\u6bb5\u5f00\u53d1\u5de5\u4f5c\u3002 KappaMab\u662f\u4e00\u79cd\u5d4c\u5408\u578bIgG1\u5355\u514b\u9686\u6297\u4f53\uff0c\u53ef\u4e0e\u4ec5\u5728\u9aa8\u9ad3\u7624\u764c\u7ec6\u80de\u8868\u9762\u53d1\u73b0\uff08\u6b63\u5e38\u7ec6\u80de\u8868\u9762\u4e0d\u8868\u8fbe\uff09\u7684\u9776\u70b9\uff0c\u5373kappa\u9aa8\u9ad3\u7624\u6297\u539f\uff08KMA\uff09\u7ed3\u5408\u3002KappaMab\u53ef\u4e0e\u9aa8\u9ad3\u7624\u7ec6\u80de\u7279\u5f02\u6027\u7ed3\u5408\uff0c\u4f7f\u60a3\u8005\u514d\u75ab\u7cfb\u7edf\u8bc6\u522b\u51fa\u5f02\u5e38\u7ec6\u80de\uff0c\u89e6\u53d1\u5929\u7136\u514d\u75ab\u5e94\u7b54\uff0c\u5bf9\u9aa8\u9ad3\u7624\u7ec6\u80de\u8fdb\u884c\u653b\u51fb\u5e76\u6740\u706d\u3002\u6700\u7ec8\uff0c\u60a3\u8005\u4f53\u5185\u4ec5\u764c\u7ec6\u80de\u51cf\u5c11\uff0c\u800c\u6b63\u5e38\u7684\u5065\u5eb7\u7ec6\u80de\u53ef\u514d\u53d7\u514d\u75ab\u7cfb\u7edf\u7684\u653b\u51fb\u3002 \u8fc4\u4eca\u4e3a\u6b62\uff0c\u5df2\u6709\u4e09\u9879\u4e34\u5e8a\u8bd5\u9a8c\u5bf9KappaMab\u8fdb\u884c\u4e86\u7814\u7a76\uff0c\u8fd9\u4e9b\u7814\u7a76\u7ed3\u679c\u5747\u8868\u660eKappaMab\u5177\u6709\u826f\u597d\u7684\u5b89\u5168\u6027\u7279\u5f81\uff0c\u4e14\u4e0d\u5177\u6709\u5355\u6b21\u3001\u591a\u6b21\u7ed9\u836f[1],[2],[3]\u540e\u5242\u91cf\u9650\u5236\u6027\u6bd2\u6027\u3002\u5728\u8fd1\u671f\u5f00\u5c55\u7684\u4e00\u9879IIb\u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\uff0c\u4e0e\u6765\u90a3\u5ea6\u80fa\u8054\u5408\u5730\u585e\u7c73\u677e\u6cbb\u7597\u76f8\u6bd4\uff08\u5bf9\u7167\u7ec4\uff09\uff0cKappaMab\u534f\u540c\u6765\u90a3\u5ea6\u80fa\uff08\u514d\u75ab\u8c03\u8282\u6027\u9170\u4e9a\u80fa\u7c7b\u836f\u7269\uff08IMiD\uff09\uff09\u8054\u5408\u5730\u585e\u7c73\u677e\u6cbb\u7597\uff0c\u53ef\u63d0\u9ad8\u590d\u53d1\u6027\u3001\u96be\u6cbb\u6027\u591a\u53d1\u6027\u9aa8\u9ad3\u76242\u60a3\u8005\u7684\u75be\u75c5\u7f13\u89e3\u7387\uff0c\u540c\u65f6\u6539\u5584\u7f13\u89e3\u8d28\u91cf\u3002 HaemaLogiX\u8463\u4e8b\u957f\u517c\u9996\u5e2d\u6267\u884c\u5b98Bryce Carmine\u8868\u793a\uff1a\u201c\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u662f\u5168\u7403\u7b2c\u4e8c\u5927\u5e38\u89c1\u7684\u6076\u6027\u8840\u6db2\u80bf\u7624\u3002\u6839\u636e2019\u5e74\u6570\u636e\uff0c\u4ec5\u5728\u7f8e\u56fd\u9884\u8ba1\u6bcf\u5e74\u5c31\u6709\u65b0\u53d1\u75c5\u4f8b3.2\u4e07\u4f8b\uff0c\u6b7b\u4ea1\u4eba\u6570\u8d851.25\u4e07\u4eba\uff0c\u6b27\u6d32\u7684\u53d1\u75c5\u7387\u5927\u81f4\u76f8\u5f53\u3002\u7531\u4e8e\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u65e0\u6cd5\u6839\u6cbb\uff0c\u6211\u4eec\u5e94\u63d0\u4f9b\u66f4\u591a\u6cbb\u7597\u65b9\u6848\u8ba9\u60a3\u8005\u9009\u62e9\u3002\u6211\u4eec\u671f\u5f85\u5c06KappaMab\u8054\u5408\u6807\u51c6\u6cbb\u7597\u91cd\u65b0\u6295\u5165\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4e0e\u9f99\u6c99\u7b7e\u8ba2\u7684\u8fd9\u9879\u534f\u8bae\u662f\u91cd\u8981\u4e00\u6b65\uff0c\u65e8\u5728\u4e3a\u6211\u4eec\u5373\u5c06\u8fdb\u884c\u7684\u8bd5\u9a8c\u63d0\u4f9b\u836f\u54c1\u3002\u201d \u6839\u636e\u534f\u8bae\u6761\u6b3e\uff0c\u9f99\u6c99\u5c06\u5728\u5176\u914d\u5907\u5148\u8fdb\u7684\u4e2d\u56fd\u5e7f\u5ddecGMP\u54fa\u4e73\u52a8\u7269\u7ec6\u80de\u65b0\u751f\u4ea7\u57fa\u5730\u4e3aKappaMab\u4e34\u5e8a\u8bd5\u9a8c\u63d0\u4f9b\u539f\u6db2\u751f\u4ea7\uff0c\u8be5\u57fa\u5730\u88c5\u8f7d\u67092\u4e2a1000L\u548c2\u4e2a2000L\u7684\u4e00\u6b21\u6027\u751f\u7269\u53cd\u5e94\u5668\u3002HaemalogiX\u5c06\u5145\u5206\u5229\u7528\u9f99\u6c99\u7684\u6cd5\u89c4\u4e13\u4e1a\u77e5\u8bc6\u3001\u5168\u7403\u751f\u4ea7\u7f51\u7edc\u4ee5\u53ca\u5728\u751f\u4ea7\u5355\u514b\u9686\u6297\u4f53\u65b9\u9762\u7684\u4e30\u5bcc\u7ecf\u9a8c\u3002 \u9f99\u6c99\u4e34\u5e8a\u5f00\u53d1\u548c\u6218\u7565\u8425\u9500\u6267\u884c\u603b\u76d1Jeetendra Vaghjiani\u8868\u793a\uff1a\u201c\u6211\u4eec\u671f\u5f85\u4e0eHaemalogiX\u5efa\u7acb\u5408\u4f5c\u5173\u7cfb\uff0c\u52a0\u901f\u63a8\u52a8\u5176\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u5019\u9009\u836f\u7269\u7684\u5546\u4e1a\u5316\u8fdb\u7a0b\uff0c\u5145\u5206\u5229\u7528\u6211\u4eec\u5728\u4e2d\u56fd\u5e7f\u5dde\u5de5\u5382\u62e5\u6709\u7684\u72ec\u7279\u3001\u7075\u6d3b\u7684\u5355\u514b\u9686\u6297\u4f53\u751f\u4ea7\u80fd\u529b\u548c\u5148\u8fdb\u7684\u4e13\u4e1a\u6280\u672f\u3002\u201d \u8be5\u836f\u54c1\u7684\u76ee\u6807\u5b8c\u6210\u65e5\u671f\u4e3a2022\u5e74\u7b2c4\u5b63\u5ea6\u3002\u76ee\u524d\u8ba1\u5212\u4e8e2022\u5e74\u5e95\u5728\u6fb3\u5927\u5229\u4e9a\u542f\u52a8\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u5c4a\u65f6\u8be5\u836f\u54c1\u5c06\u6295\u5165\u4e34\u5e8a\u4f7f\u7528\u3002 &nbsp; [1] Spencer A, Walker P, Asvadi P, et al. A preliminary study of the anti-\u03ba myeloma antigen monoclonal antibody KappaMab (MDX-1097) in pretreated patients with \u03ba-restricted multiple myeloma. Blood Cancer J. 2019; 9(8):58. [2] Kalff A, Shortt J, Yuen F,&hellip; <a class=\"read-more\" href=\"https:\/\/www.xinwengao.com\/cn\/pr\/2022012809490061638\">Read More<\/a><\/p>\n","protected":false},"author":556,"featured_media":8278,"comment_status":"close","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1965],"tags":[],"class_list":["post-61638","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-partnerships"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/61638","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/users\/556"}],"replies":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/comments?post=61638"}],"version-history":[{"count":1,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/61638\/revisions"}],"predecessor-version":[{"id":61639,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/61638\/revisions\/61639"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media\/8278"}],"wp:attachment":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media?parent=61638"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/categories?post=61638"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/tags?post=61638"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}